WS #15590
Holding: newest synthesis is 5d 7h old
Isomorphic Labs, the AI drug discovery spinout from DeepMind, has raised approximately $2.7 billion in new funding, following a $2.1 billion round five months ago. This massive capital injection underscores the continued investor confidence in AI-driven biotech and suggests a potential acceleration in drug discovery pipelines, benefiting the broader biotech sector.
Isomorphic Labs Funding Surge
Isomorphic Labs, the AI drug discovery spinout from DeepMind, has raised approximately $2.7 billion in new funding, following a $2.1 billion round five months ago. This massive capital injection underscores the continued investor confidence in AI-driven biotech and suggests a potential acceleration in drug discovery pipelines, benefiting the broader biotech sector.